Showing 7191-7200 of 9746 results for "".
- Abbott 2Q Profit Beats Expectations, Humira Sales Growhttps://practicaldermatology.com/news/20120802-abbott_2q_profit_beats_expectations_humira_sales_grow/2459757/Abbott Laboratories announced that second-quarter earnings narrowly beat estimates, fueled by the continued growth of its drug Humira. The company said net income for the quarter declined to $1.75 billion, or $1.08 per share, from $1.94 b
- CryoShape LTD Launches One-time Scar-freezing Treatmenthttps://practicaldermatology.com/news/20120802-cryoshape_ltd_launches_one-time_scar-freezing_treatment/2459758/CryoShape LTD introduced CryoShape, a new technology to reduce or eliminate keloid and hypertrophic scars, at the Aesthetic Plastic Surgery/Anti-Aging Medicine: The Next Generation Symposium in New York City July 20-22, 2012. The product uses a
- National Rosacea Society to Host 20th Anniversary Galahttps://practicaldermatology.com/news/20120730-national_rosacea_society_to_host_20th_anniversary_gala/2459759/The National Rosacea Society is hosting a 20th Anniversary Gala Celebration and Dinner on August 17, 2012, from 6-9pm at the Boston Sheraton Hotel during the summer AAD meeting to give thanks to the countless healthcare professionals who have helped improve the quality of life for rosacea patients w
- Sandoz Completes Acquisition of Fougera Pharmaceuticalshttps://practicaldermatology.com/news/20120727-sandoz_completes_acquisition_of_fougera_pharmaceuticals/2459760/Sandoz has completed its USD $1.525 billion acquisition of specialty dermatology company Fougera Pharmaceuticals. Combined with Sandoz's existing generic dermatology franchise, this acquisition positions Sandoz as the new #1 in generic dermatology
- More Than 1,000 Ulthera Systems Sold Worldwidehttps://practicaldermatology.com/news/20120725-more_than_1000_ulthera_systems_sold_worldwide/2459764/Ulthera, Inc. has sold more than 1,000 Ulthera Systems globally, with more than 100,000 treatments performed using the System. Ultherapy is a non-invasive face and neck treatment to help lift and tighten. In the first half of 2012, the company rep
- Alcohol May Influence Skin Cancer Riskhttps://practicaldermatology.com/news/20120720-alcohol_may_influence_skin_cancer_risk/2459766/Evidence suggests that alcohol consumption may have some influence on risk for developing BCC but not SCC. (J Invest Dermatol. E-pub) Consumption of wine and spirits, specifically, appears to increase BCC risk, while beer consumption does not. Results come from an analysis of data on 54,766 people e
- Ellman International Acquires Four Low-cost Lasers from Sandstonehttps://practicaldermatology.com/news/20120720-ellman_international_acquires_four_low-cost_lasers_from_sandstone/2459768/Ellman International, Inc. has acquired the assets of Sandstone Medical Technologies, LLC., a recognized leader in the aesthetic laser and IPL technology field. Sandstone's high quality laser and IPL portfolio offers four multifunctional systems, a
- gloProfessional Official Uniform Sponsor of Women's USA Field Hockey Teamhttps://practicaldermatology.com/news/20120719-gloprofessional_official_uniform_sponsor_of_womens_usa_field_hockey_team/2459769/The USA field hockey team announced a premier partnership with gloProfessional. The multi-year agreement will feature glo on the front of the Women's National Team jersey and podium suits and represents the first ever corporate advertiser
- Pycnogenol Improves Visible Signs of Aginghttps://practicaldermatology.com/news/20120718-pycnogenol_improves_visible_signs_of_aging/2459770/Pycnogenol is effective in improving visible signs of skin aging in women aged 55 to 68 years, according to a study published in a recent issue of Skin Pharmacology and Physiology. The study found that after 12 weeks of supplementing with Pycno
- Syneron Receives FDA Clearance for elōs Plushttps://practicaldermatology.com/news/20120712-syneron_receives_fda_clearance_for_els_plus/2459774/Syneron Medical Ltd. (NASDAQ: ELOS) received US Food and Drug Administration (FDA) clearance for elōs Plus, a multi-platform system featuring the company's proprietary elōs technology of optical energy and bi-polar radiofrequency. The FDA clearance follo